Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.25)
# 437
Out of 5,091 analysts
97
Total ratings
37.89%
Success rate
28.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.72 | +3.65% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $6.68 | +176.95% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.63 | +217.46% | 13 | Nov 3, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $24 | $20.96 | +14.50% | 13 | Oct 31, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $6.78 | +62.24% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $6.00 | +100.10% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.34 | +370.59% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.93 | +330.11% | 10 | Sep 3, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $1.08 | +362.96% | 6 | Aug 12, 2025 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $15.72 | -17.30% | 5 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $10.25 | +36.59% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $76.43 | -47.66% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.56 | +28.50% | 3 | Mar 26, 2025 |
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.72
Upside: +3.65%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $6.68
Upside: +176.95%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.63
Upside: +217.46%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $20.96
Upside: +14.50%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $6.78
Upside: +62.24%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $6.00
Upside: +100.10%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.34
Upside: +370.59%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.93
Upside: +330.11%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $1.08
Upside: +362.96%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $15.72
Upside: -17.30%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $10.25
Upside: +36.59%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $76.43
Upside: -47.66%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $8.56
Upside: +28.50%